Forced degradation studies of biopharmaceuticals: Selection of stress conditions.

Stability studies under stress conditions or forced degradation studies play an important role in different phases of development and production of biopharmaceuticals and biological products. These studies are mostly applicable to selection of suitable candidates and formulation developments, comparability studies, elucidation of possible degradation pathways and identification of degradation products, as well as, development of stability indicating methods. Despite the integral part of these studies in biopharmaceutical industry, there is no well-established protocol for the selection of stress conditions, timing of stress testing and required extent of degradation. Therefore, due to the present gap in the stability studies guidelines, it is the responsibility of researchers working in academia and biopharmaceutical industry to set up forced degradation experiments that could fulfill all the expectations from the stability studies of biopharmaceuticals under stress conditions. Concerning the importance of the function of desired stress conditions in forced degradation studies, the present review aims to provide a practical summary of the applicable stress conditions in forced degradation studies of biopharmaceuticals according to the papers published in a time period of 1992-2015 giving detailed information about the experimental conditions utilized to induce required stresses.

[1]  Saranjit Singh,et al.  Development of validated stability-indicating assay methods--critical review. , 2002, Journal of pharmaceutical and biomedical analysis.

[2]  B. Halle,et al.  Protein self-association induced by macromolecular crowding: a quantitative analysis by magnetic relaxation dispersion. , 2005, Biophysical journal.

[3]  R. Rustandi,et al.  Applications of CE SDS gel in development of biopharmaceutical antibody‐based products , 2008, Electrophoresis.

[4]  O. Salas-Solano,et al.  Optimization and validation of a quantitative capillary electrophoresis sodium dodecyl sulfate method for quality control and stability monitoring of monoclonal antibodies. , 2006, Analytical chemistry.

[5]  C Russell Middaugh,et al.  Effect of ionic strength and pH on the physical and chemical stability of a monoclonal antibody antigen-binding fragment. , 2013, Journal of pharmaceutical sciences.

[6]  Janice M Reichert,et al.  Antibodies to watch in 2015 , 2015, mAbs.

[7]  Hanns-Christian Mahler,et al.  Forced degradation of therapeutic proteins. , 2012, Journal of pharmaceutical sciences.

[8]  A. Mitra,et al.  Kinetics and Mechanism of Degradation of a Cyclic Hexapeptide (Somatostatin Analogue) in Aqueous Solution , 1992, Pharmaceutical Research.

[9]  A. Jouyban,et al.  A Stability Indicating Capillary Electrophoresis Method for Analysis of Buserelin , 2014, Iranian journal of pharmaceutical research : IJPR.

[10]  J. V. Van Beeumen,et al.  Photoexcitation of tryptophan groups induces reduction of two disulfide bonds in goat alpha-lactalbumin. , 2002, Biochemistry.

[11]  W Wang,et al.  Instability, stabilization, and formulation of liquid protein pharmaceuticals. , 1999, International journal of pharmaceutics.

[12]  J. Beijnen,et al.  Identification of the degradation products of gonadorelin and three analogues in aqueous solution , 1997 .

[13]  J. Fitter,et al.  Reversible and irreversible unfolding of multi-domain proteins. , 2007, Biochimica et biophysica acta.

[14]  Y. Nabuchi,et al.  The Stability and Degradation Pathway of Recombinant Human Parathyroid Hormone: Deamidation of Asparaginyl Residue and Peptide Bond Cleavage at Aspartyl and Asparaginyl Residues , 1997, Pharmaceutical Research.

[15]  V. Azimirad,et al.  A review on creatinine measurement techniques. , 2012, Talanta.

[16]  C. Russell Middaugh,et al.  Protein comparability assessments and potential applicability of high throughput biophysical methods and data visualization tools to compare physical stability profiles , 2014, Front. Pharmacol..

[17]  S. Dalmora,et al.  Stability-indicating capillary zone electrophoresis method for the assessment of recombinant human interleukin-11 and its correlation with reversed-phase liquid chromatography and biossay. , 2014, Talanta.

[18]  E. Hilder,et al.  A simple capillary electrophoresis method for the rapid separation and determination of intact low molecular weight and unfractionated heparins. , 2008, Journal of pharmaceutical and biomedical analysis.

[19]  A. R. Friedman,et al.  Effect of secondary structure on the rate of deamidation of several growth hormone releasing factor analogs. , 2009, International journal of peptide and protein research.

[20]  W. Jiskoot,et al.  Towards Heat-stable Oxytocin Formulations: Analysis of Degradation Kinetics and Identification of Degradation Products , 2009, Pharmaceutical Research.

[21]  Bernhardt L. Trout,et al.  Design of therapeutic proteins with enhanced stability , 2009, Proceedings of the National Academy of Sciences.

[22]  S. Dalmora,et al.  Stability-indicating capillary zone electrophoresis method for the assessment of recombinant human granulocyte-macrophage colony-stimulating factor and its correlation with reversed-phase liquid chromatography method and bioassay. , 2012, Talanta.

[23]  K. Storey,et al.  Real-time protein unfolding: a method for determining the kinetics of native protein denaturation using a quantitative real-time thermocycler. , 2012, BioTechniques.

[24]  Theodore W Randolph,et al.  Accelerated stability studies of abatacept formulations: comparison of freeze-thawing- and agitation-induced stresses. , 2012, Journal of pharmaceutical sciences.

[25]  C Russell Middaugh,et al.  Radar chart array analysis to visualize effects of formulation variables on IgG1 particle formation as measured by multiple analytical techniques. , 2013, Journal of pharmaceutical sciences.

[26]  J. S. Clubb,et al.  Heat stability of human placental alkaline phosphatase , 1965, Journal of clinical pathology.

[27]  W. Ward,et al.  Mechanisms of glucagon degradation at alkaline pH , 2013, Peptides.

[28]  Study of aggregation, denaturation and reduction of interferon alpha-2 products by size-exclusion high-performance liquid chromatography with fluorescence detection and biological assays. , 2010, Journal of chromatography. A.

[29]  Y. Lyubarskaya,et al.  Determination of protein oxidation by mass spectrometry and method transfer to quality control. , 2006, Journal of chromatography. A.

[30]  L. Irons,et al.  Pertussis vaccine: present status and future prospects. , 1985, Vaccine.

[31]  R. Borchardt,et al.  Kinetics of diketopiperazine formation using model peptides. , 1998, Journal of pharmaceutical sciences.

[32]  G. D. de Jong,et al.  Analysis of recombinant human growth hormone by capillary electrophoresis with bilayer-coated capillaries using UV and MS detection. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[33]  Thermal stability of the WHO international standard of interferon alpha 2b (IFN-α2b): Application of new reporter gene assay for IFN-α2b potency determinations , 2007 .

[34]  G. Scriba,et al.  Kinetics of aspartic acid isomerization and enantiomerization in model aspartyl tripeptides under forced conditions. , 2010, Journal of pharmaceutical sciences.

[35]  H. Kim,et al.  Expression of human interferon alpha-1 with enhanced stability via the tagging system of a stabilizing peptide. , 2009, Protein expression and purification.

[36]  C. Schöneich,et al.  Solid-state photodegradation of bovine somatotropin (bovine growth hormone): evidence for tryptophan-mediated photooxidation of disulfide bonds. , 2003, Journal of pharmaceutical sciences.

[37]  Y. Agrawal,et al.  Development of forced degradation and stability indicating studies of drugs—A review , 2013, Journal of pharmaceutical analysis.

[38]  M. Shimoda,et al.  Irreversible unfolding of myoglobin in an aqueous solution by supercritical carbon dioxide. , 2000, Journal of agricultural and food chemistry.

[39]  R. Beynon,et al.  Asparagine deamidation and the role of higher order protein structure. , 2008, Journal of proteome research.

[40]  A new CZE method for profiling human serum albumin and its related forms to assess the quality of biopharmaceuticals , 2011, Electrophoresis.

[41]  G. D. de Jong,et al.  Noncovalently bilayer-coated capillaries for efficient and reproducible analysis of proteins by capillary electrophoresis. , 2005, Journal of chromatography. A.

[42]  G. Hummer,et al.  The pressure dependence of hydrophobic interactions is consistent with the observed pressure denaturation of proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Theodore W Randolph,et al.  Excipient effects on humanized monoclonal antibody interactions with silicone oil emulsions. , 2012, Journal of pharmaceutical sciences.

[44]  Jinyou Zhang Mammalian Cell Culture for Biopharmaceutical Production , 2010 .

[45]  Rubén M. Maggio,et al.  Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulations , 2013 .

[46]  S J Prestrelski,et al.  Factors affecting short-term and long-term stabilities of proteins. , 2001, Advanced drug delivery reviews.

[47]  Srivalli Telikepalli,et al.  Characterization of the physical stability of a lyophilized IgG1 mAb after accelerated shipping-like stress. , 2015, Journal of pharmaceutical sciences.

[48]  A. Jouyban,et al.  Development and Validation of a Simple and Rapid Capillary Zone Electrophoresis Method for Quantification of Heparin in a PharmaceuticalProduct and Stability Studies , 2012 .

[49]  Randall J Mrsny,et al.  Formulation and delivery issues for monoclonal antibody therapeutics. , 2006, Advanced drug delivery reviews.

[50]  Hongcheng Liu,et al.  Effect of methionine oxidation of a recombinant monoclonal antibody on the binding affinity to protein A and protein G. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[51]  Lillian Li,et al.  Forced degradation studies: an essential tool for the formulation development of vaccines , 2013 .

[52]  J. B. Bogardus,et al.  Chemical and Physical Stability of Chimeric L6, a Mouse−Human Monoclonal Antibody , 1994, Pharmaceutical Research.

[53]  A. Ohtsu,et al.  The effect of pH, hydrogen peroxide and temperature on the stability of human monoclonal antibody. , 1996, Journal of pharmaceutical and biomedical analysis.

[54]  S. Singh,et al.  Frozen-state storage stability of a monoclonal antibody: aggregation is impacted by freezing rate and solute distribution. , 2013, Journal of pharmaceutical sciences.

[55]  Daniel J. Kroon,et al.  Identification of Sites of Degradation in a Therapeutic Monoclonal Antibody by Peptide Mapping , 1992, Pharmaceutical Research.

[56]  C. F. van der Walle,et al.  The effect of palmitoylation on the conformation and physical stability of a model peptide hormone. , 2014, International journal of pharmaceutics.

[57]  H. Frijlink,et al.  Potential of capillary electrophoresis for the monitoring of the stability of placental alkaline phosphatase. , 2003, Journal of pharmaceutical and biomedical analysis.

[58]  L. Kirsch,et al.  The degradation pathways of glucagon in acidic solutions. , 2000, International journal of pharmaceutics.

[59]  Jennifer Liu,et al.  Determination of tryptophan oxidation of monoclonal antibody by reversed phase high performance liquid chromatography. , 2007, Journal of chromatography. A.

[60]  A. Alexander,et al.  Monitoring of IgG antibody thermal stability by micellar electrokinetic capillary chromatography and matrix-assisted laser desorption/ionization mass spectrometry. , 1995, Analytical chemistry.

[61]  Ipsita Roy,et al.  Nucleic acid aptamers stabilize proteins against different types of stress conditions. , 2014, Journal of pharmaceutical sciences.

[62]  Ronald A Rader,et al.  (Re)defining biopharmaceutical , 2008, Nature Biotechnology.

[63]  Hui Zhao,et al.  Characterization of the photodegradation of a human IgG1 monoclonal antibody formulated as a high-concentration liquid dosage form. , 2009, Journal of pharmaceutical sciences.

[64]  Hongcheng Liu,et al.  Mass spectrometry analysis of photo-induced methionine oxidation of a recombinant human monoclonal antibody , 2009, Journal of the American Society for Mass Spectrometry.

[65]  S. Dalmora,et al.  Granulocyte-macrophage colony stimulating factor: Evaluation of biopharmaceutical formulations by stability-indicating RP-LC method and bioassay. , 2011, Biologicals : journal of the International Association of Biological Standardization.

[66]  M. Medic-Saric,et al.  Purity assessment of recombinant human granulocyte colony‐stimulating factor in finished drug product by capillary zone electrophoresis , 2014, Electrophoresis.

[67]  Hongcheng Liu,et al.  Structural effect of deglycosylation and methionine oxidation on a recombinant monoclonal antibody. , 2008, Molecular immunology.

[68]  Lee E Kirsch,et al.  The estimation of glutaminyl deamidation and aspartyl cleavage rates in glucagon. , 2004, International journal of pharmaceutics.

[69]  R. Linhardt,et al.  Accelerated stability studies of heparin. , 1996, Journal of pharmaceutical sciences.

[70]  Apollon Papadimitriou,et al.  Structure-Based Prediction of Asparagine and Aspartate Degradation Sites in Antibody Variable Regions , 2014, PloS one.

[71]  Jack Y. Zheng,et al.  Influence of pH, buffer species, and storage temperature on physicochemical stability of a humanized monoclonal antibody LA298. , 2006, International journal of pharmaceutics.

[72]  M. Etcheverrigaray,et al.  Influence of carbohydrates on the stability and structure of a hyperglycosylated human interferon alpha mutein. , 2010, Biochimie.

[73]  J. Beijnen,et al.  Degradation Kinetics of Three Gonadorelin Analogues: Developing a Method for Calculating Epimerization Parameters , 1998, Pharmaceutical Research.

[74]  John F. Carpenter,et al.  Analytical approaches to assess the degradation of therapeutic proteins , 2013 .

[75]  Theodore W Randolph,et al.  Physical instability of a therapeutic Fc fusion protein: domain contributions to conformational and colloidal stability. , 2009, Biochemistry.

[76]  K. Amighi,et al.  Stability study of full-length antibody (anti-TNF alpha) loaded PLGA microspheres. , 2014, International journal of pharmaceutics.

[77]  Vinod Kumar,et al.  Modes of Degradation and Impurity Characterization in rhPTH (1–34) during Stability Studies , 2011, PDA Journal of Pharmaceutical Science and Technology.

[78]  pH-dependent isoform transitions of a monoclonal antibody monitored by micellar electrokinetic capillary chromatography. , 1997, Analytical chemistry.

[79]  L. Kirsch,et al.  The relative rates of glutamine and asparagine deamidation in glucagon fragment 22-29 under acidic conditions. , 2002, Journal of pharmaceutical sciences.

[80]  R. Linhardt,et al.  Recent progress and applications in glycosaminoglycan and heparin research. , 2009, Current opinion in chemical biology.

[81]  A. Jouyban,et al.  A Simple Stability Indicating CZE Method for the Analysis of Octreotide Acetate , 2014, Chromatographia.

[82]  G. Rivas,et al.  Protein self‐association in crowded protein solutions: A time‐resolved fluorescence polarization study , 2004, Protein science : a publication of the Protein Society.

[83]  G. Luna‐Bárcenas,et al.  Structural and functional characterization of a recombinant leucine aminopeptidase , 2015 .

[84]  M. Fourgeaud,et al.  Comprehensive determination of the cyclic FEE peptide chemical stability in solution. , 2014, Journal of pharmaceutical and biomedical analysis.

[85]  Andreas Petzold,et al.  Identification of Potential Sites for Tryptophan Oxidation in Recombinant Antibodies Using tert-Butylhydroperoxide and Quantitative LC-MS , 2011, PloS one.

[86]  K. Hedman,et al.  Evaluation of protein‐denaturing immunoassays for avidity of immunoglobulin G to rubella virus , 1994, Journal of clinical laboratory analysis.

[87]  M. Ribela,et al.  Validation of a Stability-indicating RP-LC Method for the Assessment of Recombinant Human Interleukin-11 and Its Correlation with Bioassay , 2012, Analytical Sciences.

[88]  Angelina Taichrib,et al.  High resolution TOF MS coupled to CE for the analysis of isotopically resolved intact proteins. , 2011, Journal of proteomics.

[89]  A. Oliva,et al.  Capability measurement of size-exclusion chromatography with a light-scattering detection method in a stability study of bevacizumab using the process capability indices. , 2014, Journal of chromatography. A.

[90]  P. Rakowska,et al.  Physicochemical and biological assays for quality control of biopharmaceuticals: interferon alpha-2 case study. , 2008, Biologicals : journal of the International Association of Biological Standardization.

[91]  S. Clarke,et al.  Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. , 1987, The Journal of biological chemistry.

[92]  D. Lim,et al.  Evaluation of etanercept stability as exposed to various sugars with biophysical assessment. , 2014, International journal of pharmaceutics.

[93]  Y. Nabuchi,et al.  Oxidation of Recombinant Human Parathyroid Hormone: Effect of Oxidized Position on the Biological Activity , 1995, Pharmaceutical Research.

[94]  J. van der Greef,et al.  Characterization of Recombinant Cytokine Fragments Using Isotachophoresis-Capillary Zone Electrophoresis, Reversed-Phase High Performance Liquid Chromatography, and Mass Spectrometry , 1999, Pharmaceutical Research.

[95]  P. Deluca,et al.  Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution. , 1997, Pharmaceutical development and technology.

[96]  J. Beijnen,et al.  Analytical techniques used to study the degradation of proteins and peptides: physical instability. , 1998, Journal of pharmaceutical and biomedical analysis.

[97]  A. Eckhardt,et al.  Separation of tryptic peptides of native and glycated BSA using open-tubular CEC with salophene-lanthanide-Zn(2+) complex as stationary phase. , 2009, Journal of separation science.

[98]  J. Seelig,et al.  Thermodynamics of protein self-association and unfolding. The case of apolipoprotein A-I. , 2012, Biochemistry.

[99]  Alain Beck,et al.  Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody. , 2009, Analytical biochemistry.

[100]  A. Mauk,et al.  Self-association of a small heat shock protein. , 2005, Journal of molecular biology.

[101]  D. Chelius,et al.  Identification and characterization of oxidation and deamidation sites in monoclonal rat/mouse hybrid antibodies. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[102]  C Russell Middaugh,et al.  Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions. , 2014, Journal of pharmaceutical sciences.

[103]  V. Uversky,et al.  Effect of self-association on the structural organization of partially folded proteins: inactivated actin. , 1999, Biophysical journal.

[104]  T. H. Nguyen,et al.  Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. , 1995, Biochemistry.

[105]  B. Karger,et al.  Liquid chromatographic and capillary electrophoretic examination of intact and degraded fusion protein CTLA4Ig and kinetics of conformational transition. , 1996, Journal of chromatography. A.

[106]  R. Borchardt,et al.  Chemical Pathways of Peptide Degradation. IV. Pathways, Kinetics, and Mechanism of Degradation of an Aspartyl Residue in a Model Hexapeptide , 2004, Pharmaceutical Research.

[107]  S. Cramer,et al.  Identifying kinetically stable proteins with capillary electrophoresis , 2010, Protein science : a publication of the Protein Society.

[108]  B. Yeung,et al.  Physical Stability of Protein Pharmaceuticals , 2010 .

[109]  Brian M. Murphy,et al.  Stability of Protein Pharmaceuticals: An Update , 2010, Pharmaceutical Research.

[110]  B. Halle,et al.  Protein self-association in solution: the bovine pancreatic trypsin inhibitor decamer. , 2003, Biophysical journal.

[111]  Capillary electrophoresis-mass spectrometry using noncovalently coated capillaries for the analysis of biopharmaceuticals , 2011, Analytical and bioanalytical chemistry.

[112]  R. Borchardt,et al.  Deamidation of model β-turn cyclic peptides in the solid state , 2005 .

[113]  M. Mølhøj,et al.  Simultaneous Assessment of Asp Isomerization and Asn Deamidation in Recombinant Antibodies by LC-MS following Incubation at Elevated Temperatures , 2012, PloS one.

[114]  Hongcheng Liu,et al.  Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibody. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[115]  A. Banga Stability of Therapeutic Peptides and Proteins , 2005 .

[116]  W. Jiskoot,et al.  Comparison of analytical methods to detect instability of etanercept during thermal stress testing. , 2011, European journal of pharmaceutics and biopharmaceutics.

[117]  E. Giralt,et al.  Diketopiperazine Formation in Solid Phase Peptide Synthesis Using p‐Alkoxybenzyl Ester Resins and FMOC‐Amino Acids. , 1986 .